Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07866261
NA

Transconjunctival Versus Transcutaneous Betamethasone for Upper Eyelid Retraction in TED

Sponsor: Assiut University

View on ClinicalTrials.gov

Summary

This randomized controlled trial aims to compare the efficacy and safety of transconjunctival versus transcutaneous perilevator betamethasone injection in reducing upper eyelid retraction in patients with thyroid eye disease.

Official title: Transconjunctival Versus Transcutaneous Perilevator Betamethasone Injection for the Management of Thyroid Eye Disease-Related Upper Eyelid Retraction

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

54

Start Date

2026-10-10

Completion Date

2028-03-01

Last Updated

2026-10-08

Healthy Volunteers

No

Interventions

DRUG

Betamethasone

Betamethasone suspension 1 mL injected into the perilevator space.